Deciphera Pharmaceuticals, Inc. Restricted Investments, Noncurrent
Deciphera Pharmaceuticals, Inc. had Restricted Investments, Noncurrent of $8.13 million as of 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:RestrictedInvestmentsNoncurrent · last filed 2024-05-10
- 2024-03-31: Restricted Investments, Noncurrent $8.13M.
- 2023-12-31: Restricted Investments, Noncurrent $8.28M.
- 2023-09-30: Restricted Investments, Noncurrent $3.34M.
- 2023-06-30: Restricted Investments, Noncurrent $3.34M.
| Period end | Restricted Investments, Noncurrent |
|---|---|
| 2024-03-31 | $8.13M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $8.28M 10-Q · filed 2024-05-10 |
| 2023-09-30 | $3.34M 10-Q · filed 2023-10-30 |
| 2023-06-30 | $3.34M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $3.28M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $3.28M 10-K · filed 2024-02-07 |
| 2022-09-30 | $3.28M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $3.27M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $3.11M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $3.11M 10-K · filed 2023-02-07 |
| 2021-09-30 | $3.10M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $3.10M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $3.10M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $3.10M 10-K · filed 2022-02-08 |
| 2020-09-30 | $2.13M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $2.13M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $2.13M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $1.51M 10-K · filed 2021-02-09 |
| 2019-09-30 | $1.51M 10-Q · filed 2019-11-04 |
| 2019-06-30 | $1.51M 10-Q · filed 2019-08-02 |
| 2019-03-31 | $1.07M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $1.07M 10-K · filed 2020-03-09 |
| 2018-09-30 | $1.07M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $1.07M 10-Q · filed 2018-08-07 |